You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 8 Next »

The following Interfaces are supported as RESTful-API for deal 153-WM_LN-A_Mortgage). To expand please click on the specific line.

GET /loans/debit-credit-entries (153-WM_LN-A_Mortgage)

The following table shows for  a specific

  • tenant (companyId) and
  • deal (dealId) "001-FK_LN-A-Consumer-Annuity" and 
  • IFRS accounting rules (gaap)

the expected debit/credit entries considering  at various posting dates (postingDate)

For the explanation of data fields see here.

For an explanation of the accounting logic regarding different accounting event types refer to Loan: Examples of set of entries.


postingDate validityDateaccountingEventTypesetOfEntriesbookingSortNo debitCreditSign genledAccountNumbergenledAccountNamesignOfMeasureOrRatiomeasureOrRatioDescriptionamountOriginalcurrencyOriginalamountbal
31/12/201801/10/2018CASHFLOWLN A Capital Payout Contractual10D10622000001Loan Sub-Acc. Principal Amount-Capital amount200000,00EUR200000,00
31/12/201801/10/2018CASHFLOWLN A Capital Payout Contractual20C10622000014Loan Sub-Acc. Daily payable (Principal)-Capital amount200000,00EUR200000,00
31/12/201801/10/2018CASHFLOWLN A Capital Payout Real Payment10D10622000014Loan Sub-Acc. Daily payable (Principal)-Capital amount200000,00EUR200000,00
31/12/201801/10/2018CASHFLOWLN A Capital Payout Real Payment20C39991000001Settlement Account-Capital amount200000,00EUR200000,00
31/12/201801/10/2018IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1499,92EUR1499,92
31/12/201801/10/2018IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1499,92EUR1499,92
31/12/201805/11/2018CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account+Capital amount1660,00EUR1660,00
31/12/201805/11/2018CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
31/12/201805/11/2018CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
31/12/201805/11/2018CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount+Capital amount1660,00EUR1660,00
31/12/201805/11/2018CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount377,78EUR377,78
31/12/201805/11/2018CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income+Capital amount377,78EUR377,78
31/12/201805/11/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account+Capital amount377,78EUR377,78
31/12/201805/11/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount377,78EUR377,78
31/12/201805/12/2018CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account+Capital amount1660,00EUR1660,00
31/12/201805/12/2018CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
31/12/201805/12/2018CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
31/12/201805/12/2018CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount+Capital amount1660,00EUR1660,00
31/12/201805/12/2018CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount330,57EUR330,57
31/12/201805/12/2018CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income+Capital amount330,57EUR330,57
31/12/201805/12/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account+Capital amount330,57EUR330,57
31/12/201805/12/2018CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount330,57EUR330,57
31/12/201831/12/2018DISTR ARRLN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest273,17EUR273,17
31/12/201831/12/2018DISTR ARRLN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income+Accrual/deferral of interest273,17EUR273,17
31/12/201831/12/2018DISTR ARRLN A Accrual Incoming Interest in Arrears30D10622000008Loan Sub-Acc. Interest Portions to be amortised+Difference between contractual and effective interest rate excl. amortisation7,60EUR7,60
31/12/201831/12/2018DISTR ARRLN A Accrual Incoming Interest in Arrears40C40153000002LN Interest Smoothing Effect+Difference between contractual and effective interest rate excl. amortisation7,60EUR7,60
31/12/201831/12/2018IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1477,21EUR1477,21
31/12/201831/12/2018IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1477,21EUR1477,21
31/03/201921/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears10C10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest159,75EUR159,75
31/03/201921/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears20D40153000001LN Interest Income+Accrual/deferral of interest159,75EUR159,75
31/03/201921/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears50C40153000002LN Interest Smoothing Effect-Difference between contractual and effective interest rate excl. amortisation15,32EUR15,32
31/03/201921/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears60D10622000008Loan Sub-Acc. Interest Portions to be amortised-Difference between contractual and effective interest rate excl. amortisation15,32EUR15,32
31/03/201921/03/2019IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1438,83EUR1438,83
31/03/201921/03/2019IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1438,83EUR1438,83
31/03/201931/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest266,25EUR266,25
31/03/201931/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income+Accrual/deferral of interest266,25EUR266,25
31/03/201931/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears50D40153000002LN Interest Smoothing Effect-Difference between contractual and effective interest rate excl. amortisation6,33EUR6,33
31/03/201931/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears60C10622000008Loan Sub-Acc. Interest Portions to be amortised-Difference between contractual and effective interest rate excl. amortisation6,33EUR6,33
31/03/201931/03/2019IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1439,70EUR1439,70
31/03/201931/03/2019IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1439,70EUR1439,70
31/01/201903/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears10C10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest295,02EUR295,02
31/01/201903/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears20D40153000001LN Interest Income+Accrual/deferral of interest295,02EUR295,02
31/01/201903/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears30C10622000008Loan Sub-Acc. Interest Portions to be amortised+Difference between contractual and effective interest rate excl. amortisation7,30EUR7,30
31/01/201903/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears40D40153000002LN Interest Smoothing Effect+Difference between contractual and effective interest rate excl. amortisation7,30EUR7,30
31/01/201903/01/2019IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1477,37EUR1477,37
31/01/201903/01/2019IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1477,37EUR1477,37
31/01/201907/01/2019CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account+Capital amount1660,00EUR1660,00
31/01/201907/01/2019CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
31/01/201907/01/2019CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
31/01/201907/01/2019CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount+Capital amount1660,00EUR1660,00
31/01/201907/01/2019CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount349,65EUR349,65
31/01/201907/01/2019CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income+Capital amount349,65EUR349,65
31/01/201907/01/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account+Capital amount349,65EUR349,65
31/01/201907/01/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount349,65EUR349,65
31/01/201931/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest249,19EUR249,19
31/01/201931/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income+Accrual/deferral of interest249,19EUR249,19
31/01/201931/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears30D10622000008Loan Sub-Acc. Interest Portions to be amortised+Difference between contractual and effective interest rate excl. amortisation13,62EUR13,62
31/01/201931/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears40C40153000002LN Interest Smoothing Effect+Difference between contractual and effective interest rate excl. amortisation13,62EUR13,62
31/01/201931/01/2019IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1464,62EUR1464,62
31/01/201931/01/2019IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1464,62EUR1464,62
30/09/201830/09/2018IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1499,92EUR1499,92
30/09/201830/09/2018IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1499,92EUR1499,92
20/03/201901/02/2019DISTR ARRLN A Accrual Incoming Interest in Arrears10C10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest249,19EUR249,19
20/03/201901/02/2019DISTR ARRLN A Accrual Incoming Interest in Arrears20D40153000001LN Interest Income+Accrual/deferral of interest249,19EUR249,19
20/03/201901/02/2019DISTR ARRLN A Accrual Incoming Interest in Arrears30C10622000008Loan Sub-Acc. Interest Portions to be amortised+Difference between contractual and effective interest rate excl. amortisation13,62EUR13,62
20/03/201901/02/2019DISTR ARRLN A Accrual Incoming Interest in Arrears40D40153000002LN Interest Smoothing Effect+Difference between contractual and effective interest rate excl. amortisation13,62EUR13,62
20/03/201901/02/2019IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1464,62EUR1464,62
20/03/201901/02/2019IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1464,62EUR1464,62
20/03/201905/02/2019CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account+Capital amount1660,00EUR1660,00
20/03/201905/02/2019CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
20/03/201905/02/2019CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
20/03/201905/02/2019CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount+Capital amount1660,00EUR1660,00
20/03/201905/02/2019CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount303,36EUR303,36
20/03/201905/02/2019CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income+Capital amount303,36EUR303,36
20/03/201905/02/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account+Capital amount303,36EUR303,36
20/03/201905/02/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount303,36EUR303,36
20/03/201905/03/2019CASHFLOWLN A Capital Real Repayment10D39991000001Settlement Account+Capital amount1660,00EUR1660,00
20/03/201905/03/2019CASHFLOWLN A Capital Real Repayment20C10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
20/03/201905/03/2019CASHFLOWLN A Capital Repayment Contractual10D10622000014Loan Sub-Acc. Daily payable (Principal)+Capital amount1660,00EUR1660,00
20/03/201905/03/2019CASHFLOWLN A Capital Repayment Contractual20C10622000001Loan Sub-Acc. Principal Amount+Capital amount1660,00EUR1660,00
20/03/201905/03/2019CASHFLOWLN A Incoming Interest in Arrears Contractual10D10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount322,27EUR322,27
20/03/201905/03/2019CASHFLOWLN A Incoming Interest in Arrears Contractual20C40153000001LN Interest Income+Capital amount322,27EUR322,27
20/03/201905/03/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments10D39991000001Settlement Account+Capital amount322,27EUR322,27
20/03/201905/03/2019CASHFLOWLN A Incoming Interest in Arrears Real Payments20C10622000015Loan Sub-Acc. Daily payable (Interest)+Capital amount322,27EUR322,27
20/03/201920/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest159,75EUR159,75
20/03/201920/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income+Accrual/deferral of interest159,75EUR159,75
20/03/201920/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears50D40153000002LN Interest Smoothing Effect-Difference between contractual and effective interest rate excl. amortisation15,32EUR15,32
20/03/201920/03/2019DISTR ARRLN A Accrual Incoming Interest in Arrears60C10622000008Loan Sub-Acc. Interest Portions to be amortised-Difference between contractual and effective interest rate excl. amortisation15,32EUR15,32
20/03/201920/03/2019IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1438,83EUR1438,83
20/03/201920/03/2019IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1438,83EUR1438,83
02/01/201901/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears10C10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest273,17EUR273,17
02/01/201901/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears20D40153000001LN Interest Income+Accrual/deferral of interest273,17EUR273,17
02/01/201901/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears30C10622000008Loan Sub-Acc. Interest Portions to be amortised+Difference between contractual and effective interest rate excl. amortisation7,60EUR7,60
02/01/201901/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears40D40153000002LN Interest Smoothing Effect+Difference between contractual and effective interest rate excl. amortisation7,60EUR7,60
02/01/201901/01/2019IMPGLN A Expected Loss Stage 1 (AC)30D10622001040Loan Sub-Acc. Expected credit loss (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1477,21EUR1477,21
02/01/201901/01/2019IMPGLN A Expected Loss Stage 1 (AC)40C51820101091Loan Impairment Expense (stage 1)+Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1477,21EUR1477,21
02/01/201902/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears10D10622000002Loan Sub-Acc. Interest Accrual/Deferral+Accrual/deferral of interest295,02EUR295,02
02/01/201902/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears20C40153000001LN Interest Income+Accrual/deferral of interest295,02EUR295,02
02/01/201902/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears30D10622000008Loan Sub-Acc. Interest Portions to be amortised+Difference between contractual and effective interest rate excl. amortisation7,30EUR7,30
02/01/201902/01/2019DISTR ARRLN A Accrual Incoming Interest in Arrears40C40153000002LN Interest Smoothing Effect+Difference between contractual and effective interest rate excl. amortisation7,30EUR7,30
02/01/201902/01/2019IMPGLN A Expected Loss Stage 1 (AC)10D51820101091Loan Impairment Expense (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1477,37EUR1477,37
02/01/201902/01/2019IMPGLN A Expected Loss Stage 1 (AC)20C10622001040Loan Sub-Acc. Expected credit loss (stage 1)-Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.1477,37EUR1477,37

The following table shows for deal "153-WM_LN-A_Mortgage" expected results relevant for the gross-book-value-evidence at different posting dates. 

For the explanation of the data fields see here.



postingDate31/03/201920/03/201931/01/201902/01/201931/12/201830/09/201814/09/201813/09/2018
companyId11111111
dealId001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity
gaapIFRS9IFRS9IFRS9IFRS9IFRS9IFRS9IFRS9IFRS9
currencyDeal EUREUREUREUREUREUREUREUR
contractualRemainingCapital-27936,25-27936,25-29621,53-29621,53-30459,44-33000,00-33000,000,00
contractualRemainingCapitalBal-27936,25-27936,25-29621,53-29621,53-30459,44-33000,00-33000,000,00
dailyPayableNominal0,000,000,000,000,000,000,000,00
dailyPayableNominalBal0,000,000,000,000,000,000,000,00
dailyPayableInterest0,000,000,000,000,000,000,000,00
dailyPayableInterestBal0,000,000,000,000,000,000,000,00
dailyPayableCharge 0,000,000,000,000,000,000,000,00
dailyPayableChargeBal0,000,000,000,000,000,000,000,00
accruedInterestLinearInArrears173,28113,53177,400,00175,90112,930,000,00
accruedInterestLinearInArrearsBal173,28113,53177,400,00175,90112,930,000,00
effectiveInterestRate7,677,677,677,677,677,677,677,67
amortisedCost-27936,25-27936,25-29621,53-29621,53-30459,44-33000,00-33000,000,00
amortisedCostBal-27936,25-27936,25-29621,53-29621,53-30459,44-33000,00-33000,000,00
accruedChargesInAdvance0,000,000,000,000,000,000,000,00
accruedChargesInAdvanceBal0,000,000,000,000,000,000,000,00
accruedChargesInArrears0,000,000,000,000,000,000,000,00
accruedChargesInArrearsBal0,000,000,000,000,000,000,000,00
accruedPremiumDiscount0,000,000,000,000,000,000,000,00
accruedPremiumDiscountBal0,000,000,000,000,000,000,000,00
interestSmoothing-4,87-10,026,552,812,96-1,760,000,00
interestSmoothingBal-4,87-10,026,552,812,96-1,760,000,00
fairValueDcf28495,9128440,5930247,3029628,4530642,4833113,5933002,030,00
fairValueDcfBal28495,9128440,5930247,3029628,4530642,4833113,5933002,030,00
fairValueDcfConstantCreditSpread28495,9128440,5930247,3029628,4530642,4833113,5933002,030,00
fairValueDcfConstantCreditSpreadBal28495,9128440,5930247,3029628,4530642,4833113,5933002,030,00
stageShortNameHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHY
stageDescriptionLow credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)
eclAmountBal-210,79-210,30-223,54-222,18-229,79-248,33-247,50-247,45
unwinding0,000,000,000,000,000,000,000,00
unwindingBal0,000,000,000,000,000,000,000,00



The following table shows for a

  • specific tenant (companyId) and for
  • deal (dealId) "153-WM_LN-A_Mortgage" and for 
  • GAAP (gaap) "IFRS"

accounting transactions at various posting dates (postingDate)

For the explanation of the data fields see here.



postingDate accountingTransactionmeasureOrRatioDescriptionsignOfMeasureOrRatioamountAccountingRatiocurrencyTransactionamountAccountingRatioBalbankClientcustomerTypeproductaccountingCategoryimpairmentStageimpairmentType
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Real RepaymentCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Real RepaymentCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Repayment ContractualCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Repayment ContractualCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears ContractualCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears ContractualCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+173.28EUR173.280Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+173.28EUR173.280Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.870Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.870Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.79EUR210.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.79EUR210.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
  • No labels